There are approximately 6 million chronic wounds each year in the U.S. and these chronic wounds such as diabetic ulcers, pressure sores, and venous stasis ulcers often present necrotic eschar requiring aggressive debridement to reach healthy, sterile tissue, which can cause moderate to severe bleeding.
Tricol offers a full line of hemostatic dressings ideal for wounds prone to acute bleeding post mechanical and surgical debridement. The dressings quickly stop a range of bleeding caused by wound debridement – from oozing to severe arterial, even for patients who are on anticoagulants, while also providing antibacterial properties.
Cost-effective Tricol HemCon brand dressings enable medical staff to provide fast, effective bed-side care. This rapid bleeding control can result in less need for cauterization.